TAVR Chugging Along at 5 Years in SURTAVI Trial Plus, data suggest that it is probably cost-effective in low-risk patients Nov 06, 2021
LAA Closure Holds Up Against NOACs Longer-term follow-up from the PRAGUE-17 trial reassures Nov 05, 2021
TAVR Operators Divided on Need for Bicuspid RCT Odds of a study coming to fruition are low Nov 05, 2021
Adenosine-Free Alternative to FFR Bolstered by Longer-Term Data Physiological index boasts good 5-year results in iFR-SWEDEHEART Nov 05, 2021
No-Pressure-Wire Physiology Boosts PCI Outcomes Chinese trial shows advantage over visual assessment alone Nov 04, 2021
Surgery Keeps Edge Over Contemporary Stenting for Multivessel CAD Large noninferiority margin still not enough in FAME 3 trial Nov 04, 2021
Novel Stent Gets 'Sweet' Victory in Diabetes Patients SUGAR trial shows superiority of polymer-free stent eluting fatty acid-bound sirolimus Nov 04, 2021
A CAC Score of 0 Is Not a Clean Bill of Heart Health Plaques can still be present if symptoms are involved, especially in young people and women Oct 27, 2021
Too Many TAVR Centers Are Clustered Around Well-to-Do Communities More centers not the answer to geographic, socioeconomic disparities in access? Oct 22, 2021
Signs Point to Half-Dose DOAC Route After Watchman Procedure Search continues for best antithrombotic strategy after LAA closure Oct 13, 2021
Post-TAVR Pacemakers Not All Doom and Gloom A bit of reassurance from Swedish cohort study Oct 04, 2021
FDA Probes LAAO; Dairy Fat's Heart Benefit; Repatha OK'd for Pediatric HeFH Recent developments of interest in cardiovascular medicine Sep 28, 2021
Low Risk and Bicuspid Anatomy: A Passable Combination for TAVR Thus Far Clinical outcomes not worse compared with tricuspid TAVR Sep 21, 2021
Pipeline Flex Endovascular Flow Diverters Under Recall Serious injury and death linked to fracturing issue in the delivery system, FDA warns Sep 21, 2021
Better Late Than Never for Revascularization in STEMI Favorable outcomes for latecomers presenting up to 2 days after symptom onset Sep 20, 2021
DAPT for 1 Month Falls Short in Acute Coronary Syndrome STOPDAPT-2 ACS results can't match positive findings from earlier trials Aug 31, 2021
LAA Occluder Opens Doors to Patients Who Can't Tolerate Blood Thinners Even Briefly The Amulet IDE trial that led to Amplatzer Amulet's FDA approval Aug 30, 2021
Can Image-Guided Fibrosis Ablation Help in Persistent Afib? Targeting fibrosis in afib with minimal fibrotic disease may improve outcomes, says researcher Aug 30, 2021
Stenting or Surgery for Patients With Carotid Artery Stenosis? No differences in outcomes seen between groups Aug 30, 2021
Good Results When Giving Flu Shots to MI Survivors Still in the Hospital Vaccination prior to discharge linked to heart benefit Aug 30, 2021
Faster Not Better in Getting Cardiac Arrest Patients to the Cath Lab Brain injury is the bigger worry for most people, trial finds Aug 30, 2021
Add FFR to Diagnostic Angiography? Don't Bother RIPCORD2 gives resounding "no" on all counts Aug 29, 2021
Polypills Ready for Prime Time in Large Swaths of People, Researchers Say Question now is how to implement fixed-dose combo therapy in clinical practice Aug 29, 2021
His Bundle Pacing Stars in European Guidelines Revised edition could signal coming U.S. recommendations too Aug 29, 2021
One Month of DAPT Reasonable in Patients at High Bleeding Risk MASTER DAPT trial included "all-comer HBR population," but results were with one specific stent Aug 28, 2021
Edoxaban: A Mixed Bag for TAVR Patients Needing Anticoagulation Weighing positive efficacy data against excess GI bleeds Aug 28, 2021
Revamped Valve Disease Guideline: Europe Sees Nearly Eye to Eye With U.S. There is a different approach to deciding the suitability of TAVR, however Aug 28, 2021
Heart Failure Again Takes Center Stage at ESC EMPEROR-Preserved, new guidelines, and more to come Aug 26, 2021
Kidney Disease No Barrier to Effient Benefit in ACS Trial analysis supports superiority over ticagrelor regardless of eGFR Aug 23, 2021
Sorensen's PFO Closure Saga; Long QT and Pregnancy Loss; Another LAA Occluder OK'd Recent developments of interest in cardiovascular medicine Aug 17, 2021
Pot Smokers Face Distinct Risks After Coronary Procedures But could marijuana use be associated with fewer cases of acute kidney injury? Aug 16, 2021
Another Bioresorbable Stent Hits a Snag Did troponin elevations affect performance of Svelte stent? Aug 06, 2021
Are Hemoglobin Cutoffs for Anemia Outdated? A growing call for WHO criteria to be tightened Aug 06, 2021
TAVR Debris Deflector Doesn't Fly With FDA Advisory Panel TriGuard 3 met with skepticism in its bid for approval Aug 04, 2021
CABANA Paints Afib Ablation as Cost 'Attractive' Subanalysis results robustly inside willingness-to-pay thresholds Aug 01, 2021
LBB Pacing Linked to Better Outcomes in Comparative Study Observational findings were promising Jul 30, 2021
DOAC Reduces Stroke Risk After Ventricular Ablation Study treatment superior to aspirin, STROKE-VT trial shows Jul 29, 2021
Surprising Tradeoffs of Valve-in-Valve TAVR vs Redo Surgery Observational study suggests excess readmissions with less invasive procedure Jul 23, 2021
Watchman FLX Stays on Track for Stroke Prevention Next-generation LAA occluder maintains good results at 2 years Jul 22, 2021
